Construction of tissue-engineered homograft bioprosthetic heart valves in vitro

ASAIO Journal

Volumn 52, Issue 3, 2006, Pages 303-309

  Bin, Feng ^a   Yinglong, Liu ^b   Nin, Xie ^b   Kai, Feng ^c   Laifeng, Son ^b   Xiaodong, Zhu ^b  

^a Central Hospital of Nanchong   (China)

^b FUWAI HOSPITAL   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; BIOMEDICAL ENGINEERING; BONE; CELL CULTURE; TISSUE CULTURE;

HOMOGRAFT BIOPROSTHETIC HEART VALVES; HUMAN MESENCHYMAL STEM CELLS (MSC); PULMONARY VALVES; TISSUE ENGINEERING;

HEART VALVE PROSTHESES;

ANGIOPOIETIN RECEPTOR; DODECYL SULFATE SODIUM; VASCULOTROPIN; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER;

ADULT; AORTA VALVE; ARTICLE; BIOENGINEERING; BIOPROSTHESIS; BONE MARROW; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL MANIPULATION; CELL STIMULATION; CENTRIFUGATION; CHRONOLOGY; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; HEART VALVE PROSTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MESENCHYMAL STEM CELL; NORMAL HUMAN; PULMONARY VALVE; PULSATILE FLOW; STAINING; TISSUE ENGINEERING; ALLOTRANSPLANTATION; BONE MARROW CELL; CULTURE TECHNIQUE; CYTOLOGY; FEASIBILITY STUDY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; TIME; ULTRASTRUCTURE;

ADULT; AORTIC VALVE; BIOLOGICAL MARKERS; BIOPROSTHESIS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FEASIBILITY STUDIES; HEART VALVE PROSTHESIS; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELLS; PULMONARY VALVE; TIME FACTORS; TISSUE ENGINEERING; TRANSPLANTATION, HOMOLOGOUS;

EID: 33746712277     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mat.0000206125.81406.02     Document Type: Article

References (20)

1. Teebken OE, Wilhelmi M, Haverich A: Tissue engineering for heart valves and vascular grafts. Chirurg 76: 453-466, 2005.
2. Korossis SA, Wilcox HE, Watterson KG, et al: In-vitro assessment of the functional performance of the decellularized intact porcine aortic root. J Heart Valve Dis 14: 408-422, 2005.
3. Sutherland FW, Perry TE, Yu Y, et al: From stem cells to viable autologous semilunar heart valve. Circulation 111: 2783-2791, 2005.
4. Rabkin-Aikawa E, Mayer JE Jr, Schoen FJ: Heart valve regeneration. Adv Biochem Eng Biotechnol 94: 141-179, 2005.
5. Vesely I: Heart valve tissue engineering. Circ Res 97: 743-755, 2005.
6. Hildebrand DK, Wu ZJ, Mayer JE Jr, et al: Design and hydrodynamic evaluation of a novel pulsatile bioreactor for biologically active heart valves. Ann Biomed Eng 32: 1039-1049, 2004.
7. Rieder E, Seebacher G, Kasimir MT, et al: Tissue engineering of heart valves: Decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 111: 2792-2797, 2005.
8. Stock UA, Schenke-Layland K: Performance of decellularized xenogeneic tissue in heart valve replacement. Biomaterials 27: 000-2, 2006.
9. Feng B, Lui Y, Xie N: Fabrication of decellularized scaffold of homograft bioprosthetic tube valved with two kinds of cell detergents. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 19: 313-313, 2005.
10. Kasimir MT, Rieder E, Seebacher G, et al: Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng 11: 1274-1280, 2005.
11. Hoerstrup SP, Kadner A, Melnitchouk S et al: Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 106: I-143-I-150, 2002.
12. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cell. Science 284: 143-147, 1999.
13. Kassem M: Mesenchymal stem cells: Biological characteristics and potential clinical applications. Cloning Stem Cells 6: 369-374, 2004.
14. Nagaya N, Kangawa K, Itoh T: Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112: 1128-1135, 2005.
15. Liechty KW, Mackenzie TC, Shaaban AF, et al: Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Medicine 6: 1282-1286, 2000.
16. Oswald J, Boxberger S, Jorgensen B, et al: Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22: 377-384, 2004.
17. Ota T, Sawa Y, Iwai S, et al: Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve. Ann Thorac Surg 80: 1794-1801, 2005.
18. Cushing MC, Jaeggli MP, Masters KS, et al: Serum deprivation improves seeding and repopulation of acellular matrices with valvular interstitial cells. J Biomed Mater Res A 75: 232-241, 2005.
19. Hodde JP, Record RD, Tullius RS, et al: Retention of endothelial cell adherence to porcine-derived extracellular matrix after disinfection and sterilization. Tissue Eng 8: 225-234, 2002.
20. Fischlin T, Zilla P, Meinhart J, et al: In vitro endothelialization of amesosystemic shunt: A clinical case report. J Vasc Surg 19: 549, 1994.